Drug Availability

You are here:

Home
C19 - Updates
Drug Availability

March 20, 2020

There has been concern about drug shortages during the COVID-19 pandemic. The CLL Society investigated these concerns and has been reassured that, at least for ibrutinib, there will be no impacts to the product supply.

About the author

Brad Hedrick

Dr. Rick Furman Discusses COVID-19 and the Vaccines in Chronic Lymphocytic Leukemia (CLL) Patients, Live at the New York City CLL Society Support Group Meeting
April 12, 2021

Explaining to Family and Friends Why the CDC Guidelines for Those Vaccinated Against COVID-19 Do Not Apply to Chronic Lymphocytic Leukemia Patients
April 6, 2021

FDA Authorizes New Test Built With Machine Learning to Detect Past COVID-19 Infections
March 12, 2021

Interim Public Health Recommendations for People Fully Vaccinated Against COVID-19: What They Mean for the Chronic Lymphocytic Leukemia (CLL) Population
March 11, 2021

Tech Tips to Help Score a Covid-19 Vaccine Appointment at CVS, Rite Aid, Walgreens and More
March 7, 2021

Phase III Double-Blind, Placebo-Controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adults. (PROVENT): Worth Considering for Any Chronic Lymphocytic Leukemia (CLL) Patient
March 1, 2021